The National Institute on Aging (NIA) awarded a $454,024 Project Grant (CFDA 93.866 - Aging Research) to the Research Foundation For Mental Hygiene, Inc. (RFMH) to conduct research on high-frequency oscillations (HFOs) as a potential biomarker for Alzheimer's disease progression. The key goals of this 2-year project are to: (1) determine if HFOs originate in the hippocampus and expand to other brain regions as Alzheimer's pathology advances, (2) assess whether disrupting HFOs can improve...
This Project Grant award of $555,499 from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program will fund research to develop novel, non-invasive behavioral biomarkers for predicting seizures and mortality in mouse models of epilepsy. The primary awardee, The Leland Stanford Junior University, will use advanced 3D video analysis and artificial intelligence techniques...
The National Institute of Child Health and Human Development (NICHD) awarded a $213,750 Project Grant (CFDA 93.865 - Child Health and Human Development Extramural Research) to Children's Hospital Los Angeles (CHLA) to conduct a prospective, single-center, observational cohort study on the accuracy and feasibility of using point-of-care, low-field brain magnetic resonance imaging (POC LF-MRI) for detecting traumatic brain injuries in pediatric head trauma patients in emergency and critical care...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $234,276 over 5 years to the University of California, San Diego (UCSD) to conduct research on predicting outcomes for epilepsy surgery. The project aims to use functional MRI (fMRI) and advanced statistical/machine learning methods to identify associations between brain network...
This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), is for the "Development of Quantitative EEG Biomarkers for Smith Magenis Syndrome". The $500,500 award, effective from Jun 1, 2025 to May 31, 2027, will support research by the Children's Research Institute to retrospectively analyze overnight EEGs from children with Smith Magenis Syndrome and...
This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program, provides $408,400 to The General Hospital Corporation (doing business as Massachusetts General Hospital) to develop and assess a wearable magnetoencephalography (MEG) system for use in children. The key objectives are to: 1) Develop and optimize an age-appropriate, movement...
This $427,625 federal Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) program supports research to evaluate the use of hyperpolarized 13C magnetic resonance imaging (HPMRI) as a novel diagnostic tool for identifying epileptic tissue. The research aims to: 1) Use a rat model of temporal lobe epilepsy to explore the ability of [1-13C]pyruvate HPMRI to...
Florida International University was awarded a $250,000 Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program (CFDA 47.084) to develop an artificial intelligence-enabled real-time system for early epileptic seizure detection and prediction. The two-year project will design and develop advanced machine learning algorithms to identify neuromarkers in wearable electroencephalography data that can predict epileptic seizures. Researchers will...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $489,500 to The Children's Hospital Corporation (doing business as Boston Children's Hospital) to conduct research on identifying early neurobiological markers and developmental factors that impact language acquisition in children with autism spectrum disorder (ASD). The research aims to (1) characterize resting state EEG differences...
This Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) provides $489,500 in funding to The Children's Hospital Corporation, doing business as Boston Children's Hospital, to conduct research on early predictors of late talking and primary language impairment (PLI) in young children. The research project aims to trace longitudinal trajectories of electroencephalogram (EEG) features from 2-24 months...